Omnipod 5 Pro Tip Series
Hosted by the Juicebox Podcast

The Omnipod® 5 Automated Insulin Delivery System Pro Tip Series on the Juicebox Podcast is hosted by Scott Benner, with guest Cari Berget, RN, MPH, CDCES. In these episodes, Scott and Cari talk all things Omnipod 5 to answer your questions and help you get the most out of your Omnipod 5 experience!


Episode 1: Overview

All of your questions about SmartAdjust™ technology answered, including how to prepare for training, what to expect with your first few Pods, and tips for ongoing success.

  • 5:58 – What you need to get started
  • 11:30 – Optimizing your initial settings
  • 16:37 – Total Daily Insulin and why it matters
  • 24:55 – What to expect with your first Pod
  • 1:04:40 –Settings adjustments to consider as you get started

Episode 2: Settings

A review of the Omnipod 5 System settings to help you understand what each means and how they affect your insulin delivery.

  • 3:59 – Basal settings including initial Basal Program and Maximum Basal Rate
  • 11:19 - Target Glucose and Correct Above
  • 20:03 – Bolus settings including Insulin to Carb Ratio and Correction Factor

Episode 3: Connectivity

All about the Omnipod 5 System’s integration with the Dexcom G6 Continuous Glucose Monitor and how you can maximize time spent in Automated Mode.

  • 2:25 – Keeping your Pod and Dexcom within line of sight
  • 5:05 – Automated Mode Limited
  • 8:34 – Automated Delivery Restriction Alarms
  • 20:59 – Activity feature

Looking for even more information on Omnipod 5? Check out our most popular resources using the links below. Always consult with your Healthcare Provider before making treatment decisions about your diabetes. Insulet does not provide medical or treatment advice.

​Omnipod 5 Quick Tips​

Omnipod 5 FAQs​

Omnipod 5 Video Tutorials​

Omnipod 5 User Guide

Insulet Corporation is not affiliated, endorsed or otherwise associated with the Juicebox Podcast. Insulet has paid a fee to the host of this podcast, Scott Benner, and his guest speaker, Cari Berget, to create this content. Insulet also has an ongoing commercial relationship with both Scott and Cari.

Risk Statement
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®.

The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values.

The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.

WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.

The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit for additional important safety information.

WARNING: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.